INVESTIGADORES
FRANCHI Ana Maria
artículos
Título:
n vivo and in vitro effects of lysine clonixinate on nitric oxide synthase in LPS-treated and untreated rat lung preparations.
Autor/es:
FRANCHI ANA MARIA; DI GIROLAMO GUILLERMO; FARINA MARIANA; DE LOS SANTOS AR; MARTI ML; GIMENO MARTA ALICIA
Revista:
NITRIC OXIDE-BIOLOGY AND CHEMISTRY
Editorial:
ACADEMIC PRESS INC ELSEVIER SCIENCE
Referencias:
Lugar: Amsterdam; Año: 2001 vol. 5 p. 150 - 157
ISSN:
1089-8603
Resumen:
Recent studies have shown that some nonsteroidal antiinflammatory drugs
(NSAIDS) inhibited the inducible NO synthase (iNOS) without direct
effect on the catalytic activity of this enzyme. This study was
conducted to investigate the in vitro and in vivo effects of lysine
clonixinate (LC) and indomethacin (INDO) on NOS activity in rat lung
preparation. LC is a drug with antiinflammatory, antipyretic, and
analgesic action. In the in vitro experiments, rats were injected with
saline or lipopolysaccharide (LPS) and killed 6 h after treatment. Lung
preparations were incubated with LC at 2.3 x 10(-5) M or 3.8 x 10(-5) M.
The minimum concentration did not modify NOS activity in control or
LPS-treated rats but the maximum dose inhibited increased NO production
induced by LPS. Furthermore, INDO at 10(-6) M had no effect on enzymatic
activity in control or LPS-treated rats. In the in vivo experiments, 40
mg/kg of LC were injected ip. Such a dose did not affect basal
production of NO. When LC and LPS were injected simultaneously 6 h
before sacrifice, a significant decrease in LPS-induced NOS activity was
observed. INDO 10 mg/kg injected in control animals had no effect on
NOS activity and did not block LPS induced stimulation of NO production
when injected simultaneously. Finally, when LC (40 mg/kg) was injected 3
h after LPS, the enzymatic activity remained unchanged. Expression of
iNOS was detected by Western blotting in rats treated with LPS plus 4,
10, 20, and 40 mg/kg of LC. The lowest dose was the only one showing no
effect on LPS-induced increase of iNOS. In short, LC is a NSAID with
inhibitory action on the expression of LPS-induced NOS, effect that was
not seen with INDO in our experimental conditions.